Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with

John G Byrne1, Marzia Leacche, Daniel Unic

  • 1Department of Cardiac Surgery, Boston, MA, USA. john.byrne@vanderbilt.edu

Insights

A hybrid approach combining percutaneous coronary intervention (PCI) with valve surgery offers a superior alternative to traditional coronary artery bypass graft (CABG)/valve surgery for high-risk patients. This strategy significantly reduces mortality compared to predicted rates, though it involves increased bleeding and transfusion needs.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Technology

Background:

  • Advancements in percutaneous coronary interventions (PCIs) enable new treatment strategies.
  • Combined coronary artery and valve disease presents complex therapeutic challenges.
  • High-risk patients may benefit from alternative surgical approaches.

Purpose of the Study:

  • To evaluate the efficacy of a hybrid approach for complex coronary and valve disease.
  • To compare outcomes of hybrid treatment versus conventional coronary artery bypass graft (CABG)/valve surgery.
  • To assess the Society of Thoracic Surgeons' (STS) algorithm predictions in high-risk patients.

Main Methods:

  • Retrospective analysis of 26 high-risk patients with combined coronary and valve disease.
  • Planned initial PCI followed by valve surgery within the same hospital stay.
  • Comparison of observed mortality with STS-predicted mortality.

Main Results:

  • Operative mortality was 3.8%, significantly lower than the STS-predicted 22%.
  • Survival rates at 1, 3, and 5 years were 78%, 56%, and 44%, respectively.
  • The hybrid approach involved higher rates of bleeding and blood transfusions.

Conclusions:

  • Hybrid PCI followed by valve surgery is an excellent alternative for select high-risk patients.
  • This approach is particularly beneficial for patients presenting in shock post-myocardial infarction.
  • While mortality is reduced, increased bleeding and transfusion requirements are noted.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...